{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:23:26Z","timestamp":1765380206136,"version":"3.41.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00430","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T11:45:07Z","timestamp":1598010307000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Melanoma Inhibitory Activity (MIA) Is Able to Induce Vitiligo-Like Depigmentation in an in vivo Mouse Model by Direct Injection in the Tail"],"prefix":"10.3389","volume":"7","author":[{"given":"Matteo","family":"Bordignon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Luisetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marny","family":"Fedrigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Alaibac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15011","DOI":"10.1038\/nrdp.2015.11","article-title":"Vitiligo","volume":"1","author":"Picardo","year":"2015","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jdermsci.2013.04.005","article-title":"Role of alpha5beta1 integrin and MIA (melanoma inhibitory activity) in the pathogenesis of vitiligo","volume":"71","author":"Bordignon","year":"2013","journal-title":"J Dermatol Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1097\/01.LAB.0000097191.12477.5D","article-title":"Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity","volume":"83","author":"Bosserhoff","year":"2003","journal-title":"Lab Invest."},{"key":"B4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1046\/j.1365-2133.2003.05024.x","article-title":"Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo","volume":"148","author":"Gauthier","year":"2003","journal-title":"Br J Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1600-0749.2007.00396.x","article-title":"The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis","volume":"20","author":"Cario-Andre'","year":"2007","journal-title":"Pigment Cell Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/jid.2015.25","article-title":"Altered E-cadherin levels and distribution in melanocytes precede clinical manifestations of vitiligo","volume":"135","author":"Wagner","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/exd.12641","article-title":"Polymorphism of the E-cadherin gene CDH1 is associated with susceptibility to vitiligo","volume":"24","author":"Tarl\u00e9","year":"2015","journal-title":"Exp Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1600-0625.2012.01473.x","article-title":"Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin","volume":"21","author":"Ricard","year":"2012","journal-title":"Exp Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"11669","DOI":"10.1074\/jbc.M511367200","article-title":"Regulation of integrin activity by MIA","volume":"281","author":"Bauer","year":"2006","journal-title":"J Biol Chem."},{"key":"B10","first-page":"123","article-title":"Interferon-\u03b3 and systemic autoimmunity","volume":"16","author":"Pollard","year":"2013","journal-title":"Discov Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/1097-0142(19950115)75:2+<735::AID-CNCR2820751418>3.0.CO;2-Q","article-title":"Medical management of stage IV malignant melanoma. Medical issues","volume":"75","author":"Ho","year":"1995","journal-title":"Cancer."},{"key":"B12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000246208","article-title":"Interferon-induced vitiligo in a patient with chronic viral hepatitis C infection","volume":"193","author":"Simsek","year":"1996","journal-title":"Dermatology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1440-0960.2009.00541.x","article-title":"Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma","volume":"50","author":"Sriprakash","year":"2009","journal-title":"Aus J Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e93232","DOI":"10.1371\/journal.pone.0093232","article-title":"Interferon-\u03b3 induces senescence in normal human melanocytes","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE."},{"key":"B15","doi-asserted-by":"publisher","first-page":"100981","DOI":"10.1016\/j.arr.2019.100981","article-title":"Premature cell senescence in human skin: dual face in chronic acquired pigmentary disorders","volume":"57","author":"Bellei","year":"2020","journal-title":"Ageing Res Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/pcmr.12801","article-title":"Role of melanoma inhibitory activity in melanocyte senescence","volume":"32","author":"Feuerer","year":"2019","journal-title":"Pigment Cell Melanoma Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fendo.2017.00290","article-title":"Vitiligo and autoimmune thyroid disorders","volume":"8","author":"Baldini","year":"2017","journal-title":"Front Endocrinol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1755-148X.2011.00838.x","article-title":"Koebner's phenomenon in vitiligo: European position paper","volume":"24","author":"van Geel","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/jdv.14792","article-title":"Critical appraisal of the oxidative stress pathway in vitiligo: a systematic review and meta-analysis","volume":"32","author":"Speeckaert","year":"2018","journal-title":"J Eur Acad Dermatol Venereol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00430\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T11:45:08Z","timestamp":1598010308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00430\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":19,"alternative-id":["10.3389\/fmed.2020.00430"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00430","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2020,8,21]]},"article-number":"430"}}